Deutsche Bank Initiates Coverage on Lannett Company to Hold

Deutsche Bank Initiates Coverage on Lannett Company(NYSE:LCI). The shares have been rated Hold. The rating by Deutsche Bank was issued on Jun 29, 2016.

Lannett Company (LCI) made into the market gainers list on Fridays trading session with the shares advancing 4.83% or 1.15 points. Due to strong positive momentum, the stock ended at $24.94, which is also near the day’s high of $25.08. The stock began the session at $23.79 and the volume stood at 8,88,621 shares. The 52-week high of the shares is $62.9 and the 52 week low is $16.91. The company has a current market capitalization of $916 M and it has 3,67,47,501 shares in outstanding.

Lannett Company(LCI) last announced its earnings results on May 3, 2016 for Fiscal Year 2016 and Q3.Company reported revenue of $163.71M. Analysts had an estimated revenue of $160.49M. Earnings per share were $0.75. Analysts had estimated an EPS of $0.61.

Several Insider Transactions has been reported to the SEC. On Jun 24, 2016, Robert Ehlinger (VP and CIO) sold 37,141 shares at $25.07 per share price.Also, On Feb 8, 2016, Albert Iii Paonessa (director) purchased 2,500 shares at $24.57 per share price.On Feb 8, 2016, Martin P Galvan (CFO) purchased 3,000 shares at $24.65 per share price, according to the Form-4 filing with the securities and exchange commission.

Lannett Company Inc. develops manufactures markets and distributes generic versions of brand pharmaceutical products. The Company’s products include Levothyroxine Sodium tablets Digoxin tablets Butalbital products Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with around 12 varying potencies. Digoxin tablets are produced and marketed with approximately two different potencies. It distributes around three products containing Butalbital. Ursodiol capsules are produced and marketed in 300 milligram capsules. The Company offers a range of pain management products such as Cocaine Topical Solution (C-Topical) Morphine Sulfate Oral Solution Hydromorphone hydrochloric acid (HCl) tablets and Codeine Sulfate tablets.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Lannett Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Lannett Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.